Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Dexpramipexole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,826Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Areteia Posts Ph. 3 Asthma Win for Oral Rival to Biologic Drugs
    Areteia Posts Ph. 3 Asthma Win for Oral Rival to Biologic Drugs

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250916566261/en/Areteia-Therapeutics-Announces-Positive-Topline-Results-from-the-First-Phase-III-Study-of-Oral-Dexpramipexole-in-Eosinophilic-Asthma

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    Areteia Therapeutics Announces Additional $75MM in Series A Financing
    Areteia Therapeutics Announces Additional $75MM in Series A Financing

    13 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240213672000/en

    BUSINESSWIRE
    13 Feb 2024
    Share Share
    Areteia Therapeutics Announces Publication of PII Data of Oral Dexpramipexole
    Areteia Therapeutics Announces Publication of PII Data of Oral Dexpramipexole

    03 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230803161391/en

    BUSINESSWIRE
    03 Aug 2023
    Share Share
    Areteia Announces Start of Phase III Trials of Oral Dexpramipexole
    Areteia Announces Start of Phase III Trials of Oral Dexpramipexole

    09 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230309005048/en

    BUSINESSWIRE
    09 Mar 2023
    Share Share
    Bain leads $350M bet on oral asthma startup to fund phase 3
    Bain leads $350M bet on oral asthma startup to fund phase 3

    12 Jul 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/bain-goes-big-again-leading-350m-round-fund-oral-challenger-blockbuster-asthma-biologics

    Nick Paul Taylor FIERCEBIOTECH
    12 Jul 2022
    Share Share
    Knopp Bio Presents New Phase 2 Data at AAAAI 2022 on Oral Dexpramipexole
    Knopp Bio Presents New Phase 2 Data at AAAAI 2022 on Oral Dexpramipexole

    28 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220228005167/en

    BUSINESSWIRE
    28 Feb 2022
    Share Share